13F-HR/A filed by Sofinnova Investments, Inc.
Sofinnova Investments, Inc. filed this 13F-HR/A for the quarter ended 2023-12-31, filed 2024-08-15, with 62 holding rows worth $1,787,596,851.
- Accession
- 0001104659-24-090054
- Filer
- CIK 1631134
- Filed
- 2024-08-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2023
A holdings report, amendment of type restatement, 64 entries on the cover page, a total value of $1,787,596,851 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,787,596,851 with VALUE read as dollars as filed, 13F file number 028-18774. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| KARUNA THERAPEUTICS INC | 48576A100 | COM | 1,381,149 | $437,147,470 | dollars as filed | |
| RAYZEBIO INC | 75525N107 | COM | 2,419,528 | $150,422,056 | dollars as filed | |
| NATERA INC COM | 632307104 | Stock | 1,550,280 | $97,109,539 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 754,032 | $94,970,330 | dollars as filed | |
| Merck & Co.,Inc. | 58933Y105 | COM | 857,971 | $93,535,998 | dollars as filed | |
| AEROVATE THERAPEUTICS INC | 008064107 | COM | 3,758,686 | $85,059,064 | dollars as filed | |
| ASTRAZENECA PLC SPONSORED ADR | 046353108 | ADR | 850,577 | $57,286,361 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 3,467,156 | $53,324,859 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 1,458,881 | $51,906,986 | dollars as filed | |
| IMMUNOGEN INC | 45253H101 | COMMON STOCK | 1,546,902 | $45,865,644 | dollars as filed | |
| Intuitive Surgical,Inc. | 46120E602 | COM | 126,959 | $42,830,888 | dollars as filed | |
| Eli Lilly and Company | 532457108 | COM | 64,525 | $37,612,913 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 414,207 | $34,582,142 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 844,008 | $33,473,357 | dollars as filed | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 1,411,769 | $33,345,984 | dollars as filed | |
| IMMATICS N.V | N44445109 | SHS | 2,969,039 | $31,263,981 | dollars as filed | |
| SANOFI SA SPONSORED ADR | 80105N105 | ADR | 598,978 | $29,787,176 | dollars as filed | |
| INHIBRX INC | 45720L107 | COM | 772,957 | $29,372,366 | dollars as filed | |
| KENVUE INC | 49177J102 | COM | 1,206,939 | $25,985,397 | dollars as filed | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 1,667,321 | $23,976,076 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 1,075,786 | $23,247,735 | dollars as filed | |
| MARINUS PHARMACEUTICALS INC | 56854Q200 | COM NEW | 1,772,699 | $19,269,238 | dollars as filed | |
| Stryker Corporation | 863667101 | COM | 62,788 | $18,802,494 | dollars as filed | |
| INCYTE CORP COM | 45337C102 | Stock | 296,569 | $18,621,568 | dollars as filed | |
| GERON CORP | 374163103 | COM | 8,814,497 | $18,598,589 | dollars as filed | |
| INOZYME PHARMA INC | 45790W108 | COM | 4,280,308 | $18,234,112 | dollars as filed | |
| ELANCO ANIMAL HEALTH INC COM | 28414H103 | Stock | 1,193,885 | $17,788,887 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 44,721 | $17,013,210 | dollars as filed | |
| Y-mAbs Therapeutics Inc | 984241109 | Common Stock | 2,194,278 | $14,964,976 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 510,441 | $14,317,870 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 1,013,505 | $13,479,617 | dollars as filed | |
| AGENUS INC | 00847G705 | COM NEW | 15,656,234 | $12,961,796 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 2,382,835 | $11,199,325 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 352,397 | $10,402,759 | dollars as filed | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 429,395 | $9,747,267 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 222,553 | $9,376,158 | dollars as filed | |
| Boston Scientific Corporation | 101137107 | COM | 131,000 | $7,573,110 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 174,838 | $7,126,397 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 113,757 | $6,869,785 | dollars as filed | |
| INSULET CORP COM | 45784P101 | Stock | 19,000 | $4,122,620 | dollars as filed | |
| IRONWOOD PHARMACEUTICALS INC | 46333X108 | COMMON STOCK | 331,099 | $3,787,773 | dollars as filed | |
| BOLT BIOTHERAPEUTICS INC | 097702104 | COM | 2,754,437 | $3,084,969 | dollars as filed | |
| NEXTCURE INC | 65343E108 | COM | 2,671,856 | $3,045,916 | dollars as filed | |
| DEXCOM INC COM | 252131107 | Stock | 20,000 | $2,481,800 | dollars as filed | |
| THE COOPER COMPANIES | 216648402 | COM NEW | 4,000 | $1,513,760 | dollars as filed | |
| MASIMO CORP COM | 574795100 | Stock | 12,800 | $1,500,288 | dollars as filed | |
| NUCANA PLC | 67022C106 | ADR | 4,684,120 | $1,385,563 | dollars as filed | |
| AGENUS INC | 00847G705 | COM NEW | 1,600,000 | $1,324,640 | dollars as filed | call |
| FUSION PHARMACEUTICALS INC | 36118A100 | COM | 125,299 | $1,204,123 | dollars as filed | |
| MARINUS PHARMACEUTICALS INC | 56854Q200 | COM NEW | 100,000 | $1,087,000 | dollars as filed | call |
| IMMATICS N.V | N44445117 | *W EXP 07/01/202 | 318,372 | $929,646 | dollars as filed | |
| IKENA ONCOLOGY INC | 45175G108 | COM | 363,479 | $716,054 | dollars as filed | |
| Nucana PLC | GB00BYWYV | COMMON SHARES | 2,400,000 | $709,920 | dollars as filed | |
| PDS BIOTECHNOLOGY CORP | 70465T107 | COM | 142,635 | $708,896 | dollars as filed | |
| PENUMBRA INC COM | 70975L107 | Stock | 2,000 | $503,080 | dollars as filed | |
| GALERA THERAPEUTICS EQUICLASS EQUITY | 36338D108 | COMMON STOCK | 3,083,712 | $448,372 | dollars as filed | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 28,600 | $193,050 | dollars as filed | |
| PEPGEN INC COM | 713317105 | Stock | 23,038 | $156,658 | dollars as filed | |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 3,052 | $79,016 | dollars as filed | |
| SPRUCE BIOSCIENCES INC | 85209E109 | COM | 22,767 | $66,707 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 1,200 | $48,300 | dollars as filed | |
| VIR BIOTECHNOLOGY INC | 92764N102 | COM | 4,495 | $45,220 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-24-015432 | superseded | 2024-02-13 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001104659-24-090054 | this filing | 2024-08-15 | acceptance time not in the bulk data set |